Premier (PINC) Tops Q3 EPS by 1c, Revenues Miss; Offers FY19 EPS/Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Premier, Inc. (PINC) PT Raised to $42 at Cowen
May 7, 2019 3:54 PM EDTCowen analyst Charles Rhyee raised the price target on Premier, Inc. (NASDAQ: PINC) to $42.00 (from $41.00) while maintaining a Market Perform rating.
Q3 mixed but incrementally more positive on longer-term outlook.... MorePremier (PINC) to Exit Specialty Pharmacy Business
May 6, 2019 5:28 PM EDTPremier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is exiting its specialty pharmacy business to enhance the companys focus on the continuing evolution of its core supply chain, enterprise analytics and performance improvement capabilities.
On May 6, 2019, certain of Premiers consolidated subsidiaries entered into a definitive asset purchase and sale agreement with ProCare Pharmacy, L.L.C., a subsidiary of CVS Health Corporation, under which Premier will sell certain assets related to its specialty pharmacy business for $22.5 million, plus up to an additional $20.0 million for inventory, each subject to... More
